Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 5 | -$0.36 | -$0.35 | -$0.36 |
Q2 2025 | 2 | -$0.38 | -$0.38 | -$0.38 |
Q3 2025 | 2 | -$0.41 | -$0.41 | -$0.41 |
Q4 2025 | 2 | -$0.42 | -$0.42 | -$0.42 |
Q1 2026 | 1 | -$0.35 | -$0.35 | -$0.35 |
Q2 2026 | 1 | -$0.35 | -$0.35 | -$0.35 |
Q3 2026 | 1 | -$0.37 | -$0.37 | -$0.37 |
Q4 2026 | 1 | -$0.37 | -$0.37 | -$0.37 |
Mind Medicine (MindMed) Inc. last posted its earnings results on Thursday, March 6th, 2025. The company reported $-0.41 earnings per share for the quarter, missing analysts' consensus estimates of $-0.33 by $0.08. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Mind Medicine (MindMed) Inc. has generated $-2 earnings per share over the last year ($-0.15 diluted earnings per share) and currently has a price-to-earnings ratio of -4.98. Mind Medicine (MindMed) Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
03/06/2025 | Q4 2024 | -$0.33 | -$0.41 | -0.08 | $0 | $0 |
11/07/2024 | Q3 2024 | -$0.29 | -$0.18 | 0.11 | $0 | $0 |
08/13/2024 | Q2 2024 | -$0.30 | -$0.08 | 0.22 | $0 | $0 |
05/08/2024 | Q1 2024 | -$0.66 | -$1.14 | -0.48 | N/A | $0 |
02/28/2024 | Q4 2023 | -$0.48 | -$0.59 | -0.11 | N/A | $4.84 M |
11/02/2023 | Q3 2023 | -$0.65 | -$0.45 | 0.2 | N/A | $0 |
08/03/2023 | Q2 2023 | -$0.54 | -$0.76 | -0.22 | N/A | $0 |
05/04/2023 | Q1 2023 | -$0.41 | -$0.72 | -0.31 | N/A | $0 |
03/09/2023 | Q4 2022 | -$0.49 | $0.11 | 0.6 | N/A | $0 |
11/10/2022 | Q3 2022 | -$0.58 | -$0.55 | 0.03 | N/A | $0 |
08/11/2022 | Q2 2022 | -$0.75 | -$0.60 | 0.15 | N/A | $0 |
05/16/2022 | Q1 2022 | -$0.75 | -$0.66 | 0.09 | N/A | $0 |
11/12/2021 | Q4 2021 | -$0.52 | -$3.32 | -2.8 | N/A | $0 |
08/12/2021 | Q3 2021 | N/A | -$0.83 | N/A | N/A | $0 |
08/12/2021 | Q2 2021 | N/A | -$1.34 | N/A | N/A | $0 |
03/31/2021 | Q1 2021 | N/A | -$0.57 | N/A | N/A | $0 |
12/31/2020 | Q4 2020 | N/A | -$0.48 | N/A | N/A | $0 |
09/30/2020 | Q3 2020 | N/A | -$0.46 | N/A | N/A | $0 |
06/30/2020 | Q2 2020 | N/A | -$0.33 | N/A | N/A | $0 |
03/31/2020 | Q1 2020 | N/A | -$0.52 | N/A | N/A | $0 |
Mind Medicine (MindMed) Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
The conference call for Mind Medicine (MindMed) Inc.'s latest earnings report can be listened to online.
The conference call transcript for Mind Medicine (MindMed) Inc.'s latest earnings report can be read online.
Mind Medicine (MindMed) Inc. (:MNMD) has a recorded net income of $-108,679,000.Mind Medicine (MindMed) Inc. has generated $-1.54 earnings per share over the last four quarters.
Mind Medicine (MindMed) Inc. (:MNMD) has a price-to-earnings ratio of -4.98 and price/earnings-to-growth ratio is -0.55.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED